Bookmark

Add to MyYahoo RSS

Salix Pharmaceuticals News

News on Salix Pharmaceuticals (Ticker: SLXP) continually updated from thousands of sources around the net.

19 hrs ago | Freshnews

Salix Pharmaceuticals and Progenics Pharmaceuticals Announce the...

RALEIGH, N.C. & TARRYTOWN, N.Y. -- -- Salix Pharmaceuticals, Ltd. and Progenics Pharmaceuticals, Inc. announced today that the submission to the European Medicines Agency of RELISTOR Subcutaneous Injection for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, has been accepted for review.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Progenics Pharmaceuticals, Raleigh, NC, Marketing, Food and Drug Administration

Thu Apr 17, 2014

Business Journal

Analysts: Salix is one of the most undervalued pharmas

At least that's what analysts at brokerage firm Sterne Agee say. They identified Salix Pharmaceuticals as "heavily skewed to the upside" in front of new data the company will soon release on Xifaxan, its leading drug, and sees the company as a "strong candidate to participate in the ongoing consolidation across the sector."

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Wed Apr 16, 2014

AmericanBankingNews.com

Salix Pharmaceuticals Now Covered by Analysts at Sterne Agee

The firm set a "buy" rating on the stock. A number of other analysts have also recently weighed in on SLXP.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Apr 14, 2014

AmericanBankingNews.com

Salix Pharmaceuticals Receives Average Recommendation of "Hold" from Brokerages

Shares of Salix Pharmaceuticals have received an average recommendation of "Hold" from the eighteen ratings firms that are presently covering the company, Analyst RN reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Apr 08, 2014

Sys-Con Media

Upcoming Events, Shares, Stock Price Updates, Notes Exchange Offer,...

Upcoming Events, Shares, Stock Price Updates, Notes Exchange Offer, Clinical Study Results and New Product Launch - Analyst Notes on Salix, Endo, ISIS, IDEXX, and Novo Today, Analysts Review released its analysts' notes regarding Salix Pharmaceuticals, Ltd. , Endo International PLC , ISIS Pharmaceuticals, Inc. , IDEXX Laboratories, Inc. , and Novo ... (more)

Comment?

Related Topix: Biotech, Medicine, IDEXX Laboratories, Healthcare Industry, Endo Pharmaceuticals Holdings, Novo Nordisk AS, Isis Pharmaceuticals

Mon Apr 07, 2014

Contract Pharma Breaking News

Icon Bioscience Appoints CEO

David S. Tierney, MD has been appointed president and chief executive officer of Icon Bioscience, Inc. Dr. Tierney is an accomplished healthcare executive with significant experience in successfully developing and commercializing drug delivery platforms.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Apr 03, 2014

Business Journal

The List: Triangle's largest M&A deals in 2013

The Triangle's five largest deals with known values in 2013 totaled about $6.9 billion, a figure dwarfed by 2012's top five total value of $37.8 billion, which included the blockbuster Duke Energy purchase of Progress Energy.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••